Recall: D-0241-2026

Class II - Potentially Harmful

Class IIClassification

2025-12-12Initiated

OngoingStatus

Merck Sharp & Dohme LLCFirm

Product

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Reason

Presence of particulate matter: potential presence of metal particulates in the product.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.